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Spider silks have remarkable physical properties due to a 
combination of strength and elasticity. In addition, spider silks 
are biocompatible and biodegradable. Our laboratory has 
shown that the strength of products, such as fibers, produced 
with other silk proteins correlates with the size of the silk 
protein. The aciniform silk protein (AcSp1), has been shown 
to produce the thinnest and strongest fibers of all the natural 
spider silks. Aciniform silk is composed of a nonrepetitive 
amino-terminal region, 14 repeats of approximately 200 
amino acids each, and a nonrepetitive carboxy-terminal 
region. We have been able to produce different variants of this 
gene. All AcSp1 protein variants were able to express in 
E. coli. The bacteria expression of the AcSp1 protein is low 
and the protein is expressed not only as a full length 
polypeptide but also as fragments of the protein. We identified 
a sequence in the amino-terminal region of the first repeat of 
the AcSp1 gene that acts as an early termination sequence.
Our objective is to modify this region on the gene to study 
changes in the expression efficiency of AcSp1.
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Methods
•The strategy to convert high-usage codons into 
low-usage codons by E. coli increased the efficiency 
of AcSp1 expression in variant LoFi.
•Replacing the sequence of the N-terminus of the 
second repeat by the one of the first repeat resulted in 
a much higher expression of AcSp1 (NT1).
•Neither variant shows a reduction of the number of 
partial-length polypeptides of AcSp1.
Future work
Future work remains to be done in order to increase the 
expression of a full length protein.
•Study additional domains of the gene by mutagenesis.
•Express AcSp1 proteins with higher number of repeats.
Conclusions
An Aciniform gene was synthesized based on its 
protein sequence. The synthetic gene encodes for two 
identical repeats. Two new variants of the gene were 
generated by site directed mutagenesis which was
performed using single stranded DNA (ssDNA).
Two oligonucleotides (LoFi and NT1) were designed 
to introduce several mutations in the synthetic gene.
Results
Figure 3. Western Blot of Aciniform 2 repeats. Lanes 1: MW markers, 
2: AcSp1 synthetic gene 2 repeats, 3: AcSp1 LoFi mutant, 4: AcSp1 
NT1 mutant. Samples were standardized by optical density (OD600).
Arrow indicates full length AcSp1.
High-usage (ratio) codons replaced by low-usage codons
Original sequence
Ratio      0.27   0.43  0.43   0.13  0.38   0.22   0.70   0.27    
5' AGC   ACC   ACC   AGT   GGT   GCA   GAA   AGC 3'
S         T        T        S        G        A        E         S         
LoFi mutant
Ratio      0.13   0.13  0.21             0.13                         0.13            
5' AGT ACT ACT AGT   GGG GCA   GAA   AGT 3'
S         T        T        S        G        A        E         S        
N-terminus of second repeat replaced by N-terminus of first 
repeat
Original sequence
5' GGC   GGT   TAT   CCT   GGC   GGT   TAC   CCA   GGC  GGA 3‘
G        G       Y       P         G       G Y        P        G       G
NT1 mutant
5' GGT GGT   TAT   CCG GGT GGC   TAT CCT GGT GGT 3'
G        G       Y        P        G        G       Y        P       G       G       
First repeat          Second repeat
LoFi NT1NT1
AcSp1 gene
Figure 1: A) Mass Spectrometry chromatograph of the 
purified truncated polypeptide. The major peak indicates its 
molecular mass and allowed us to determine the sequence of 
the polypeptide. B) AcSp1 protein sequence (2 repeats) and 




We have generated two variants of the AcSp1 synthetic gene: 
LoFi and NT1. Both variants have a much higher expression 
than the original synthetic gene (Fig. 3). The changes have not 










Figure 2: Model represents the site where the mRNA
stalls during translation, resulting in an early termination 
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